Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. [electronic resource]
Producer: 20120320Description: 477-84 p. digitalISSN:- 1432-0843
- Administration, Oral
- Adult
- Aged
- Anorexia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Hand-Foot Syndrome -- etiology
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Pancreatic Neoplasms -- drug therapy
- Prospective Studies
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.